about
Synovial Sarcoma in a Neonate.Gastric cancer in IndiaCurrent therapy and recent advances in the management of retinoblastoma.Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol.Synovial sarcoma of kidney in a child: A rare presentation.Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia.Prognostic markers in osteosarcoma.Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.Pediatric nasopharyngeal carcinoma: Experience from a tertiary cancer center in India.Management of Hepatoblastoma: ICMR Consensus Document.Management of Hodgkins Lymphoma: ICMR Consensus Document.Management of Pediatric Malignant Germ Cell Tumors: ICMR Consensus Document.Management of Wilms Tumor: ICMR Consensus Document.Management of Neuroblastoma: ICMR Consensus Document.Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document.Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India.Nutritional profile of pediatric cancer patients at Cancer Institute, Chennai.Bloodstream infections in pediatric patients at Cancer Institute, Chennai.Prevalence of multi-drug resistant organisms in stool of paediatric patients with acute leukaemia and correlation with blood culture positivity: A single institution experience.Multiple Myeloma in an 8-Year-Old Child With HIV Infection.Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib.Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.Lomustine induced acute pulmonary toxicity in a pediatric medulloblastoma survivor.Recent advances in the management of multiple myeloma.Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings.Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome.Chikungunya Fever With Seizures, Myocarditis, and Severe Thrombocytopenia in a Child With Osteosarcoma.Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India.MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy.Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre.Ewing sarcoma of the clavicle: a case series.Acanthamebic meningoencephalitis presenting as personality change.Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study.Increasing incidence of multidrug-resistant Gram-negative septicaemia during induction therapy of acute myeloid leukaemia.Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective studyEfficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis SyndromeFactors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.VEGF expression in residual tumor cells in orbital retinoblastoma (IRSS stage III) treated with NACT: a prospective study
P50
Q34677239-90E7B150-23EF-4F09-B3E7-FBCCB02E1C2FQ35073299-5BCC6C15-89F0-427A-931C-6F06929F6122Q36228138-62C758C6-43E0-4E9C-AC3E-861A9D8334C5Q36458018-A898A061-061D-4D9A-B80D-AAF759E1923CQ36683015-18767E69-FA1F-4EBA-983C-E1EFF33146D7Q36696390-D09177AB-38E4-4B71-B910-620FDC6577D3Q37687395-1A4672C6-AB4C-47EA-A6CE-0CA03E4176F6Q38371659-1E7D2E94-6582-429B-8253-43F68240A544Q38937731-6D9929B6-8E34-4C84-9068-DA60AB48FF3EQ39206308-806F2AAD-B5CE-40D4-ACE9-6D79DAE0DAE6Q39208309-A0409670-6164-4093-9482-B17204F36DD1Q39212387-9F73C1F6-550C-4FCC-9501-7C90BFAA507AQ39214593-52363134-6D32-4B96-B566-4ABF28351737Q39214599-7A7DFAE4-9712-4467-BF5E-CD35561021ECQ39220842-9C9CC563-CBCA-45BA-907C-9706389546B7Q39589791-0E4BB615-4055-4DCC-BED7-46FDF01CBB5CQ40016553-7EC6D02A-E718-47BC-8B7F-E690FB56FA98Q40027016-4C5CD00B-B27F-4B54-A99C-755ACD64601CQ40110143-330FC8A7-95ED-4E51-92F4-27E60EE92471Q40461397-D00AD8F9-B297-413E-89D7-98B4AF695BF7Q40813998-29F9DFD8-CCDA-4EF9-8004-EF0ED920E087Q41378943-D150B016-4798-4BB8-8CA2-1854A7C213ECQ42292880-58F11489-0204-47CD-AEE1-C888E0C12694Q42769794-FD1EAAC8-2B7D-4436-A4D1-21635C033B49Q42869911-13B11A97-AC44-476D-96CF-9C8F977CE843Q43556585-C590BAE4-C2A9-4272-B6B9-0EFBFFEB9D6EQ44065723-F12F12E9-3EB5-4D93-8EE0-973F54764270Q44845558-5BE351AE-FE3C-4757-9CCD-0717D3C753F4Q44853741-184884B5-36DB-4B38-A3B2-F1CAFCDD471CQ45324458-016A8C05-5E44-44FD-8E98-59817B770ADDQ47296270-9A7A623E-F4B9-4EEF-87C8-D41C361FE6A3Q50092825-64A9CDA3-F3F6-4A2D-BB6D-66E9BC148D93Q51527385-6A1F48E4-CF37-4E32-9569-5AA31E876D0FQ51868467-7A41F83D-9B57-420A-BB6F-DC77DB8BB417Q53180140-81993316-BD55-4BFA-BBB9-9275B446A1F1Q53784947-6938FD04-DFC0-4EB9-9CB6-26594405D2B7Q56775195-E5FC343A-1BEC-426C-B616-C6BD01021BFCQ58125072-325DD412-F00C-4376-AA0D-AF0854962DEDQ64951806-46D7C6FF-C698-44DE-9F9A-8C631F023F46Q82521037-A6082782-2E17-4C98-960F-DE97430127D7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Venkatraman Radhakrishnan
@ast
Venkatraman Radhakrishnan
@en
Venkatraman Radhakrishnan
@es
Venkatraman Radhakrishnan
@nl
Venkatraman Radhakrishnan
@sl
type
label
Venkatraman Radhakrishnan
@ast
Venkatraman Radhakrishnan
@en
Venkatraman Radhakrishnan
@es
Venkatraman Radhakrishnan
@nl
Venkatraman Radhakrishnan
@sl
altLabel
Venkatraman R
@en
prefLabel
Venkatraman Radhakrishnan
@ast
Venkatraman Radhakrishnan
@en
Venkatraman Radhakrishnan
@es
Venkatraman Radhakrishnan
@nl
Venkatraman Radhakrishnan
@sl
P106
P31
P496
0000-0002-7557-5816